Identification of high-risk cutaneous melanoma tumors is improved when combining the online American Joint Committee on Cancer Individualized Melanoma Patient Outcome Prediction Tool with a 31-gene expression profile–based classification

Abstract

The GEP provides valuable prognostic information and improves identification of high-risk melanomas when used together with the AJCC online prediction tool.